Drug intelligence / Profile preview

salicylic acid + ciclopirox olamine

Development stage
Unknown
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Based on the search results, I can provide the following information about the combination drug salicylic acid + ciclopirox olamine: The combination of salicylic acid and ciclopirox olamine is a topical antifungal medication primarily used to treat various scalp conditions including seborrheic dermatitis, dandruff, and fungal infections. ## Formulation and Composition This medication is typically formulated as a shampoo containing ciclopirox olamine (1-1.5%) and salicylic acid (2-3%)[1][3]. The combination leverages the antifungal properties of ciclopirox olamine with the keratolytic effects of salicylic acid to provide dual action against fungal infections and scale removal[3][8]. ## Mechanism of Action Ciclopirox olamine is a hydroxypyridone derivative antifungal agent that differs in structure and mechanism from other antifungals[10]. It works by inhibiting the growth of fungi through regulating DNA replication and blocking essential enzymes for this process[6]. It has broad-spectrum antifungal activity against dermatophytes, yeasts, and other fungi[10]. Salicylic acid functions as a keratolytic agent, helping to shed dead skin cells from the top layer of the skin[3]. This action enhances the penetration of ciclopirox olamine and aids in removing scales associated with conditions like seborrheic dermatitis. ## Clinical Applications The combination is primarily used for: - Seborrheic dermatitis of the scalp - Dandruff - Tinea versicolor - Pityriasis - Fungal scalp infections A clinical study demonstrated that a shampoo containing 1.5% ciclopirox olamine and 3% salicylic acid was effective in treating dandruff and seborrheic dermatitis, showing significant improvement throughout treatment and during follow-up[8]. The combination was particularly effective at reducing itching associated with seborrheic dermatitis compared to other treatments[8]. ## Regulatory Status According to the search results, some formulations of this combination have not been found by the FDA to be safe and effective, and their labeling has not been approved by the FDA[1][2]. This suggests that while the individual components are approved drugs, certain specific combination products may be considered unapproved or compounded medications. ## Administration The shampoo formulation is typically applied to the scalp and used three times per week for a treatment period of approximately 4 weeks[8]. The medication should be used as directed by a healthcare provider and not for longer than the prescribed period. ## Side Effects Common side effects may include skin itching, burning sensation, or redness at the application site[6][9]. Most of these side effects do not require medical attention and typically resolve over time, but persistent or worsening side effects should be reported to a healthcare provider.

02

Targets

Stratum corneum barrier (Corneocyte keratin and intercellular cement)

Beyond the preview

Go deeper on salicylic acid + ciclopirox olamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salicylic acid + ciclopirox olamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call